Court Allows Fraud Allegation In Medtronic False Claims Act Case; Upholds Dismissal Of Kickback, Off-Label Claims

The Ninth Circuit is resurrecting a claim that Medtronic misled the US FDA about a product’s intended use so it could be cleared via the 510(k) pathway, but didn’t take up allegations of off-label marketing or kickbacks.